Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Bril F, Kalavalapalli S, Lomonaco R, Cusi K.Diabetes Obes Metab. 2023 Apr;25(4):1112-1116. doi: 10.1111/dom.14936.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?